Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
ABCD ScoreAdjusted Body WeightBody Mass IndexDiaRem ScoreIdeal Weight & Excess Weight Loss
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

DiabetologiaJun 6, 2026
Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial

Clinical Context

We think this has broad domain relevance to DiaRem Score — T2DM Remission Predictor.

DiabetologiaJun 6, 2026
Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages

Clinical Context

We think this has broad domain relevance to DiaRem Score — T2DM Remission Predictor.

Emerging Infectious DiseasesJun 5, 2026
Clinical Predictors of Fatal Outcomes from Human Leptospirosis, Thailand, 2015–2024

Clinical Context

We think this might be relevant to the clinical guidance for DiaRem Score — T2DM Remission Predictor.

DiaRem Score

Clinical Validation Hub

The DiaRem score is validated across RYGB, LSG, and LAGB procedures in white and Hispanic populations.

Yrs
%

Ready for Assessment

Based on patient age, baseline HbA1c, and pharmacological burden.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

Pre-operative evaluation of patients with Type 2 Diabetes Mellitus (T2DM) undergoing Roux-en-Y Gastric Bypass (RYGB).
Predicting the probability of complete T2DM remission (HbA1c < 6.5% and fasting glucose < 126 mg/dL without medication) at 5 years post-surgery.
Assisting in shared decision-making regarding the metabolic benefits of bariatric surgery.

Patient Population

Specifically validated for patients undergoing RYGB. While used off-label for other procedures, its predictive accuracy is highest for gastric bypass cohorts.

Last Comprehensive Review: 2026